First human test of new leukemia drug duo offers hope for tough cases
Disease control
Recruiting now
This is an early safety study for adults whose acute myeloid leukemia (AML) has come back or not responded to standard treatment. Researchers are testing a new combination of two drugs, bomedemstat and venetoclax, to find the safest dose and see if the body can tolerate them. The…
Phase: PHASE1 • Sponsor: Terrence J Bradley, MD • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC